LPU
LLY icon

Lansdowne Partners (UK)’s Eli Lilly LLY Stock Holding History

Lansdowne Partners (UK)’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,647
Closed -$13M – 26
2024
Q3 		$13M Sell
14,647
-851
-5% -$765K 1.01% 11
2024
Q2 		$14M Sell
15,498
-14,791
-49% -$11.8M 1.1% 12
2024
Q1 		$23.6M Sell
30,289
-17,556
-37% -$12.5M 1.52% 11
2023
Q4 		$27.9M Buy
47,845
+14,994
+46% +$8.75M 2.05% 12
2023
Q3 		$17.6M Sell
32,851
-22,371
-41% -$11.5M 1.61% 12
2023
Q2 		$25.9M Buy
55,222
+23,782
+76% +$9.97M 2.87% 8
2023
Q1 		$10.8M Buy
+31,440
New +$10.6M 1.67% 9

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Lansdowne Partners (UK)'s LLY Position: Q4 2024 in Review

Lansdowne Partners (UK) sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 14,647 shares — an estimated $13M sold.

Lansdowne Partners (UK) first reported a position in LLY in Q1 2023 and held it in 7 quarters. The position peaked at $27.9M in Q4 2023. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Lansdowne Partners (UK) reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Lansdowne Partners (UK) sold 14,647 Eli Lilly shares in Q4 2024, an estimated $13M.
  • Lansdowne Partners (UK) first reported a position in Eli Lilly in Q1 2023 and held it in 7 quarters.
  • Lansdowne Partners (UK)'s Eli Lilly position peaked at $27.9M in Q4 2023.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Lansdowne Partners (UK)'s 13F filing for Q4 2024, filed 13 Feb 2025.